These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 936072)

  • 1. Change of the molecular mass of fibrinogen in circulating blood, as an index of the hypercoagulable states.
    Kazama M; Abe T
    Thromb Res; 1976 May; 8(2 suppl):133-42. PubMed ID: 936072
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical significance of the plasminogen level.
    Lackner H; Javid JP
    Am J Clin Pathol; 1973 Aug; 60(2):175-81. PubMed ID: 4720396
    [No Abstract]   [Full Text] [Related]  

  • 3. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
    Rocha E; López Borrasca A
    Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen and its derivatives, hereditary and acquired abnormalities.
    Marder VJ; Buszynski AZ
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1338-42. PubMed ID: 4421373
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.
    Damus PS; Wallace GA
    Thromb Res; 1975 Jan; 6(1):27-38. PubMed ID: 46627
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis.
    Nossel HL
    N Engl J Med; 1976 Aug; 295(8):428-32. PubMed ID: 59314
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble fibrinogen/fibrin complexes in pre-eclampsia.
    McKillop C; Forbes CD; Howie PW; Prentice CM
    Lancet; 1976 Jan; 1(7950):56-8. PubMed ID: 54580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
    Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S
    Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of fibrinogen degradation products in serum and urine as a new diagnostic tool.
    Nilsson IM
    Scand J Haematol Suppl; 1971; 13():317-22. PubMed ID: 4945833
    [No Abstract]   [Full Text] [Related]  

  • 11. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state.
    Joist JH
    Am J Gastroenterol; 1999 Oct; 94(10):2801-3. PubMed ID: 10520824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic diagnosis of intravascular blood clotting and intravascular thrombus formation among patients with ischemic heart disease].
    Khalfen ESh; Ikonnikova EI; Filippova SB; Voronkova LI
    Kardiologiia; 1985 Sep; 25(9):94-8. PubMed ID: 4079233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of fibrinopeptide A by high performance liquid chromatography and its significance.
    Mao P; Wang BM; Shen D; Wei WN
    Chin Med J (Engl); 1988 May; 101(5):353-6. PubMed ID: 3145836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum alpha 2 H in malignant hemopathies and cirrhosis. Prognostic value].
    Martin JP; Charlionet R; Ropartz C
    Presse Med (1893); 1971 Nov; 79(51):2313-6. PubMed ID: 4108548
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology and treatment of thrombosis. 1. Hypercoagulable state. (1) Study on the role of tissue thromboplastin in the formation of thrombosis].
    Kobayashi N
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):2-7. PubMed ID: 3553378
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinogen-fibrin-related antigen pattern in human blood. Differences between plasma and serum from pateints with disseminated intravascular coagulation.
    Jacobsen CD; Hoak JC; Wu KK; Fry GL
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):266-76. PubMed ID: 4217475
    [No Abstract]   [Full Text] [Related]  

  • 18. Disseminated intravascular coagulation with elevated platelet count and fibrinogen.
    Bessman JD; Bell WR
    N Engl J Med; 1978 Nov; 299(19):1076. PubMed ID: 703777
    [No Abstract]   [Full Text] [Related]  

  • 19. The plasma gelation by ethanol in the diagnosis of disseminated intra-vascular coagulation.
    Samama M; Conard J
    Kobe J Med Sci; 1972 Mar; 18(1):11-4. PubMed ID: 4643912
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease.
    Mason JW; Colman RW
    Thromb Diath Haemorrh; 1971 Oct; 26(2):325-31. PubMed ID: 5134485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.